CDT Equity Inc. — Form SCHEDULE 13D/A
Filed November 6, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
▲ Likely positive
significance 92/100
What the filing says
Dr. Andrew Regan, through Corvus Capital Limited and Manoira Limited, holds 2,064,698 shares (22.15% of CDT Equity Inc.) and proposes acquiring all outstanding shares at $2.00/share—a 96.3% premium to the $1.018 closing price on November 4, 2026. CDT's market cap is ~$1.036M while stockholders' equity is ~$103M and Sarborg holdings valued at ~$161M, creating a significant discount-to-assets that Regan attributes to chronic dilution from at-the-market issuances and reverse splits. Corvus demands the board suspend ATM offerings, form an independent committee, and respond within 5 days.
Why this rating
Proposal values company at ~$2.0M (18× current market cap), addresses existential financing crisis, directly threatens current capital structure and control. Business-changing for $55K-scale micro-cap.
Tradability signal
NO TRADE
No trade: price $0.01 is below our $0.5 floor — spreads at this level eat any edge. (Filing arrived outside market hours — evaluated at the next open with a live quote.)
Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.
Price action (we called it positive)
at our read · unknown $0.01 | +10 min · unknown $0.01 ▲ 16.67% | +30 min · unknown $0.01 ▲ 16.67% | +1 hr · unknown $0.01 ▲ 16.67% | +4 hrs · unknown $0.00 ▼ 33.33% |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from November 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.